OR5D17P: A Potential Drug Target and Biomarker (G81196)
OR5D17P: A Potential Drug Target and Biomarker
OR5D17P, a member of the Olfactory Receptor Family 5 (ORF5), is a pseudogene that encodes a protein involved in the sense of smell. The ORF5 gene is located on chromosome 6p21.1 and has been implicated in various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. OR5D17P is a potential drug target and biomarker due to its unique expression pattern and its potential role in the development of these disorders.
The Olfactory Receptor Family 5 (ORF5) is a subfamily of the G protein-coupled receptor (GPCR) family. GPCR is a large family of transmembrane proteins that play a crucial role in sensory perception, including the sense of smell. ORF5 is a single gene that encodes the OR5 protein, which is a key component of the olfactory system. The OR5 protein is expressed in the central nervous system (CNS) and is involved in the sense of smell.
Pseudogenes are genes that encode proteins that are not present in the reference genome. OR5D17P is a pseudogene that has been identified by bioinformatics analysis of gene expression data. OR5D17P is a single exon gene that encodes a protein of approximately 120 amino acids. The OR5D17P gene has been shown to be expressed in various tissues and organs, including brain, heart, and muscle.
The potential drug target status of OR5D17P is based on its expression pattern in neurodegenerative diseases. Neurodegenerative diseases are a group of disorders that are characterized by the progressive loss of neural cells and their functions. These disorders include Alzheimer's disease, Parkinson's disease, and Huntington's disease. OR5D17P is expressed in the CNS and is involved in the sense of smell. Therefore, it is possible that OR5D17P may be a drug target for the treatment of neurodegenerative diseases.
In addition to its potential drug target status, OR5D17P has also been shown to be a potential biomarker for neurodegenerative diseases. The sense of smell is a critical sense that is involved in various physiological and psychological processes. Therefore, changes in the sense of smell can be an indicator of neurodegeneration. OR5D17P has been shown to be expressed in the CNS and to be involved in the development of various neurological disorders. Therefore, it is possible that OR5D17P may be a useful biomarker for the diagnosis and monitoring of neurodegenerative diseases.
OR5D17P has also been shown to play a role in the development of psychiatric disorders. Studies have shown that OR5D17P is expressed in the brain and is involved in the development of various psychiatric disorders, including depression and anxiety. Therefore, it is possible that OR5D17P may be a potential drug target for the treatment of psychiatric disorders.
In conclusion, OR5D17P is a pseudogene that encodes a protein involved in the sense of smell. Its expression pattern and potential role in the development of neurodegenerative diseases and psychiatric disorders make it an attractive drug target and biomarker. Further research is needed to determine the exact function of OR5D17P and its potential clinical applications.
Protein Name: Olfactory Receptor Family 5 Subfamily D Member 17 Pseudogene
The "OR5D17P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5D17P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3
